FibroBiologics, Inc. - Common Stock Q2 EPS $(0.12) Misses $(0.11) Estimate

FibroBiologics, Inc. - Common Stock (NASDAQ: FBLG) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 500 percent decrease over earnings of $0.03 per share from the same period last year.